Skip to main content
Clinical Trials/TCTR20230916002
TCTR20230916002
Enrolling By Invitation
Phase 3

Comparing the Efficacy of Perioperative Pain Control Between Intravenous Parecoxib and Oral Etoricoxib in ACL Reconstruction: A Randomized Controlled Trial

Faculty of Medicine, Prince of Songkla University0 sites160 target enrollmentSeptember 16, 2023

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Anterior cruciate ligament injury patients which underwent anterior cruciate ligament reconstruction surgery.
Sponsor
Faculty of Medicine, Prince of Songkla University
Enrollment
160
Status
Enrolling By Invitation
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 16, 2023
End Date
October 1, 2025
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Faculty of Medicine, Prince of Songkla University

Eligibility Criteria

Inclusion Criteria

  • The patients diagnosed as anterior cruciate ligament injury aged 18\-50 years old who scheduled for arthroscopic ACLR.

Exclusion Criteria

  • 1\. Patient who schedules for bone\-patellar tendon\-bone autograft ACL reconstruction
  • 2\. Allergy to acetaminophen, aspirin, sulfonamide, NSAIDs or opioids
  • 3\. History of dyspepsia, peptic ulcer, or abnormal bleeding
  • 4\. History of ASCVD (History of diagnosis ACS, clinical likely ACS)
  • 5\. History of CKD
  • 6\. History of asthma or COPD because selective COX\-inhibitor induce spasm
  • 7\. History of cerebrovascular disease
  • 8\. History of peripheral arterial disease
  • 9\. Patients who have Kratom or Marijuana used or substance abuse
  • 10\. Patients who anesthesiologist concerns the risk of general anesthesia (GA) is higher than spinal anesthesia; hence, they prefer to use spinal anesthesia rather than general anesthesia

Outcomes

Primary Outcomes

Not specified

Similar Trials